← All trials
NCT05124691
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 17, 2022
- Primary completion
- Jun 30, 2023
- Completion date
- Jun 30, 2023
- First posted
- Nov 18, 2021
- Last posted
- Nov 18, 2021
- Enrollment
- 1223
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of BarcelonaLead sponsor
- University of LondonCollaborator
- Leiden UniversityCollaborator
- Kenya Medical Research InstituteCollaborator
- Universidad de LeónCollaborator
- European and Developing Countries Clinical Trials Partnership (EDCTP)Collaborator
- Centro de Investigacao em Saude de ManhicaCollaborator
- Bahir Dar UniversityCollaborator
- University of BarcelonaOverall official - principal investigator
- Iberica Co. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.